Search details
1.
Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy.
BJU Int
; 133(3): 297-304, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37548533
2.
An Update on the Treatment of Papillary Renal Cell Carcinoma.
Cancers (Basel)
; 15(3)2023 Jan 17.
Article
in English
| MEDLINE | ID: mdl-36765524
3.
Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors.
Clin Genitourin Cancer
; 21(1): 69-75, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36509613
4.
Characterizing the relationships between tertiary and community cancer providers: Results from a survey of medical oncologists in Southern California.
Cancer Med
; 10(16): 5671-5680, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34331372
5.
Tumor Mutational Burden in Metastatic Castration-Resistant Prostate Cancer and Response to Checkpoint Inhibition.
JAMA Oncol
; 10(4): 531-532, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-38329743
6.
Cytoreductive Nephrectomy in 2021: Obsolete.
Eur Urol Open Sci
; 36: 44-46, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34988492
7.
Switch maintenance therapy for advanced bladder cancer: A paradigm shift in 2020.
Cancer Treat Res Commun
; 24: 100202, 2020.
Article
in English
| MEDLINE | ID: mdl-32805533
8.
Giant-cell tumor of bone: treatment options and role of denosumab.
Biologics
; 9: 69-74, 2015.
Article
in English
| MEDLINE | ID: mdl-26203221
Results
1 -
8
de 8
1
Next >
>>